DailyUpdates for Clinical Trials
LeadDiscovery's proprietary ClinSearch technology is used to identify news clinical trials as they are opened. Trials judged to be of key importance are featured on DailyUpdates.
Latest Clinical Trials
- Phase 1 Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma
- Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome (MDS) Who Are Candidates For Allogeneic Hematopoietic Cell Transplant
- A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors
- A Phase 1/2, Multi-Center, Open-Label, Dose-Escalation Study of HuLuc63 (Humanized Anti CS1 Monoclonal IgG1 Antibody) and Bortezomib in Subjects With Multiple Myeloma Following One to Three Prior Therapies. (HuLuc63-1702)